help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 28, 2008
Endocrinology, doi:10.1210/en.2007-0438
A more recent version of this article appeared on June 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/6/3046    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mokhtari, D.
Right arrow Articles by Welsh, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mokhtari, D.
Right arrow Articles by Welsh, N.

Submitted on April 4, 2007
Accepted on February 15, 2008

The MAPK kinase kinase-1 is essential for stress-induced pancreatic islet cell death

Dariush Mokhtari, Jason W Myers, and Nils Welsh*

Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden; Department of Biochemistry, Stanford University School of Medicine, Stanford California, USA

* To whom correspondence should be addressed. E-mail: Nils.Welsh{at}mcb.uu.se.

The aim of the present investigation was to characterize the role of the MAPK kinase kinase-1 (MEKK-1) in stress-induced cell death of insulin producing cells. We observed that transient overexpression of the wild type (wt) MEKK-1 protein in the insulin-producing cell lines RIN-5AH and {beta}TC-6 increased JNK phosphorylation and augmented cell death induced by DETA/NONOate (DETA/NO), Streptozotocin (STZ) and hydrogen peroxide (H2O2). Furthermore, DETA/NO or STZ induced a rapid threonine phosphorylation of MEKK-1. Silencing of MEKK-1 gene expression in {beta}TC-6 and human dispersed islet cells, using in vitro generated diced siRNA (d-siRNA), resulted in protection from DETA/NO, STZ, H2O2 and Tunicamycin induced cell death. Moreover, in DETA/NO-treated cells d-siRNA-mediated down-regulation of MEKK-1 resulted in decreased activation of JNK, but not of p38 and ERK. Inhibition of JNK by treatment with SP600126 partially protected against DETA/NO- or STZ-induced cell death. In summary, our results support an essential role for MEKK-1 in JNK-activation and stress-induced {beta}-cell death. Increased understanding of the signaling pathways that augment or diminish {beta}-cell MEKK-1 activity may aid in the generation of novel therapeutic strategies in the treatment of Type 1 diabetes.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society